A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning

Immunotherapy by using immune checkpoint inhibitors (ICI) has dramatically improved the treatment options in various cancers, increasing survival rates for treated patients. Nevertheless, there are heterogeneous response rates to ICI among different cancer types, and even in the context of patients...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Polano, Maurizio, Chierici, Marco, Dal Bo, Michele, Gentilini, Davide, Di Cintio, Federica, Baboci, Lorena, Gibbs, David L., Furlanello, Cesare, Toffoli, Giuseppe
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2019
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6827166/
https://ncbi.nlm.nih.gov/pubmed/31618839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101562
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki